STROKE WITH TRANSFUSIONS CHANGING TO HYDROXYUREA (SWITCH)

这个子项目是许多利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 输血改为羟基脲治疗的卒中：一项比较标准疗法（红细胞输注+铁离子螯合）与替代疗法（羟基脲+静脉切开术）预防继发性卒中和管理镰状细胞贫血和既往卒中儿童患者铁超负荷的III期随机临床试验

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Stroke With Transfusions Changing To Hydroxyurea (Switch): A Phase III Randomized Clinical Trial To Compare Standard Theraphy (Erythrocyte Transfusions With IRon Chelation) With Alternative Therapy (Hydroxyurea With Phlebotomy) For The Prevention Of Secondary Stroke And The Management Of Iron Overload in Pediatric Subjects With Sickle Cell Anemia And Previous Stroke